Empiric Therapy for Gastroesophageal Reflux Disease

Archives of Internal Medicine

Volumn 155, Issue 16, 1995, Pages 1808-1812

  Schindlbeck, Norbert E ^a   Klauser, Andreas G ^a   Voderholzer, Winfried A ^a   Müller Lissner, Stefan A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; DOSE RESPONSE; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PH MEASUREMENT; PRIORITY JOURNAL; STOMACH ACID;

ADULT; AGED; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OMEPRAZOLE; RANITIDINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0029123702     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1995.00430160156016     Document Type: Article

References (25)

1. Colin-Jones DG, Bloom B, Bodemar G, et al. Management of dyspepsia: report of a working party. Lancet. 1988;1:576-579.
2. Hannay DR. Symptom prevalence in the community. J R Coll Gen Pract. 1978; 28:492-499.
3. Heading RC. Epidemiology of oesophageal reflux disease. Scand J Gastroenterol. 1989;24(suppl 168):33-37.
4. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Dig Dis Sci. 1976;21:953-956.
5. Klauser AG, Voderholzer WA, Knesewitsch PA, Schindlbeck NE, Müller-Lissner SA. What is behind dyspepsia? Dig Dis Sci. 1993;38:147-154.
6. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastrooesophageal reflux disease. Lancet. 1990;335:205-208.
7. DeMeester TR, Wang C-I, Wernly JA, et al. Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg. 1980; 79:656-670.
8. Klauser AG, Heinrich C, Schindlbeck NE, Müller-Lissner SA. Is long-term esophageal pH monitoring of clinical value? Am J Gastroenterol. 1989;84: 362-366.
9. Schindlbeck NE, Heinrich Ch, König A, Dendorfer A, Pace F, Müller-Lissner SA. Optimal thresholds, sensitivity and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology. 1987;93: 85-90.
10. Schindlbeck NE, Ippisch H, Klauser AG, Müller-Lissner SA. Which pH-threshold is best in esophageal pH-monitoring? Am J Gastroenterol. 1991;86: 1138-1141.
11. Walther B, DeMeester TR. Placement of the esophageal pH electrode for 24-hour esophageal pH monitioring. In: DeMeester TR, Skinner DB, eds. Esophageal Disorders: Pathophysiology and Therapy. New York, NY: Raven Press; 1985:539-541.
12. Emde C, Garner A, Blum AL. Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut. 1987;28:1177-1188.
13. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Esophageal 24-h pH monitoring: is prior manometry necessary for correct positioning of the electrode? Am J Gastroenterol. 1990;85:1463-1467.
14. Schindlbeck NE, Klauser AG, Voderholzer WA, Müller-Lissner SA. Mean acidity or percentage reflux time in oesophageal pH-monitoring? Eur J Gastroenterol Hepatol. 1993;5:155-159.
15. Bell NJV, Hunt RH. Role of gastric acid suppression in the treatment of gastrooesophageal reflux disease. Gut. 1992;33:118-124.
16. Collen MJ, Strong RM. Comparison of omeprazole and ranitidine in the treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Dig Dis Sci. 1992;37:897-903.
17. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology. 1988;95:903-912.
18. Koelz HR. Treatment of reflux esophagitis with H2-blockers, antacids and pro-kinetic drugs: an analysis of randomized clinical trials. Scand J Gastroenterol. 1989;24(suppl 156):25-36.
19. Olbe L, Lundell L. Medical treatment of reflux esophagitis. Hepatogastroenterology. 1992;39:322-324.
20. Fiorucci S, Santucci L, Morelli A. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis. Am J Gastroenterol. 1990;85:1458-1462.
21. Sontag SJ, Hirschowitz BI, Holt S, et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S Multicenter Study. Gastroenterology. 1992;102:109-118.
22. Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts J-L. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci. 1988;33:523-529.
23. Young MF, Sanowski RA, Talbert GA, Harrison ME, Walker BE. Omeprazole administration as a test for gastroesophageal reflux. Gastroenterology. 1992; 102:192. Abstract.
24. Bates S, Sjödén P-O, Fellenius J, Nyrén 0. Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects. Gastroenterology. 1989;97:376-383.
25. George AA, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology. 1991;101:3-6.